Implementation of Remote Supportive Care Programs to Women at Risk for and Surviving with Breast and Ovarian Cancer During the COVID-19 Pandemic

November 2021 Vol 12, No 11
Adina Fleischmann, LSW
Sharsheret, Teaneck, NJ
Elana Silber, MBA
Sharsheret, Teaneck, NJ
Melissa Rosen, MA
Sharsheret, Teaneck, NJ
Sydney Campbell, BS
Lombardi Comprehensive Cancer Center
Washington, DC
Nikoleta Marku
Lombardi Comprehensive Cancer Center
Washington, DC
Catherine Dunn, BS
Sharsheret, Teaneck, NJ
Tania Lobo, MS
Teaneck, NJ
Kenneth P. Tercyak, PhD
Sharsheret, Teaneck, NJ

Background: The COVID-19 global pandemic created significant challenges in providing screening, treatment, and support services to women at risk for and living with breast and ovarian cancer. These individuals have unique socio-emotional needs (eg, stress, fear of recurrence, caregiving, employment, financial hardship) that preceded the pandemic and intensified during COVID-19. Sharsheret, a national nonprofit organization helping Jewish women with breast and ovarian cancer, provides informative and supportive programming to address these needs. In response to the pandemic, the organization implemented a range of programs specifically designed for this population during a time of crisis.

Objectives: To describe the psychosocial care needs of women impacted by breast and ovarian cancer, the COVID-19 pandemic, and the implementation of resources to meet these needs.

Methods: Outcome data from 345 respondents were collected in early 2021, including data from a special COVID-19 impact survey evaluating remote programs offered during the pandemic.

Results: Among respondents, 19% were most concerned about financial hardship during the pandemic due to loss of/changes in employment, insurance, or other income; 16% also expressed concern about obtaining care and support. Respondents expressed high satisfaction with the programs and services offered, as 64% highly valued online educational webinars, and 51% valued experiential workshops and essential connections with Sharsheret’s clinical staff. The implementation of such programs supported women in maintaining their physical health, mental health, and overall well-being in the midst of a global pandemic.

Conclusion: Success of these remote care services offered during COVID-19 highlights the necessity of implementing opportunities for continued psychosocial programming. Insights gleaned from this evaluation serve to inform on how to best educate and counsel women at risk for and surviving with breast and ovarian cancer during times of crisis.

Related Articles
Assessment of Side Effects (SEs) Impacting Quality of Life (QOL) in Patients (Pts) Undergoing Treatment (tx) for Advanced Breast Cancer (ABC) in Clinical Practice: A Real-World (RW) Multicountry Survey
November 2022 Vol 13, No 11
To examine how SEs impacting QOL in pts with ABC are perceived.
Intracranial Activity of Tepotinib in Patients with MET Exon 14 (METex14) Skipping Non–Small-Cell Lung Cancer (NSCLC) Enrolled in VISION
November 2022 Vol 13, No 11
To provide analysis of the intracranial activity of tepotinib in patients with METex14 skipping NSCLC with BM from the VISION study to aid oncology nurse navigators who manage this population of patients.
MOMENTUM: Phase 3 Randomized Study of Momelotinib (MMB) versus Danazol (DAN) in Symptomatic and Anemic Myelofibrosis (MF) Patients Previously Treated with a JAK Inhibitor
November 2022 Vol 13, No 11
MF is a rare bone marrow cancer characterized by fibrosis, abnormal blood cell production, and dysregulated JAK/STAT signaling.1,2
Last modified: August 10, 2023

Subscribe Today!

To sign up for our print publication or e-newsletter, please enter your contact information below.

I'd like to receive:

  • First Name *
    Last Name *
    Profession or Role
    Primary Specialty or Disease State